Company: RGNT
Filing Date: 2025-05-05
Form Type: F-1/A
Source: 0001213900-25-039589
Chunk: 277

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-05
Form: F-1/A
Chunk 277
---
 dividends have been declared to date.

Other distributions described in the
AOA as follows: If the Company declares a distribution payable in securities of other persons, evidences of indebtedness issued by the
Company or other persons, assets (excluding cash dividends) or options or rights, or if the Company at any time pays a dividend payable
in additional Ordinary Shares or other securities or rights convertible into, or entitling the holder thereof to receive directly or
indirectly, additional Ordinary Shares, then, in each such case, the holders of preferred shares is entitled to receive such distribution
in respect of their holdings on an as-converted basis as of the record date for such distribution.

| b. | Conversion Rights |

Each preferred share is convertible,
at the option of the holder thereof, into such number of fully paid and non-assessable Ordinary Shares at a 1:1 ratio, subject to certain
adjustment such as splits and combinations, recapitalization, adjustments for dividend or other distribution as fully described in the
AOA.

| c. | Automatic and Mandatory Conversion |

Each preferred share automatically
converts without payment of additional consideration into Ordinary Shares at the conversion rate (as described above) then in effect:
(i) immediately prior to the closing of a QIPO (means the closing of an IPO at a pre-money equity valuation of the Company of at least
$120,000, generating minimum net proceeds of at least $25,000), subject to the consummation of such QIPO; or (ii) at the written request
of the holders of at least a qualified majority of the issued preferred shares.

<div align='center'>F-24</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 10:- | TEMPORARY EQUITY (Cont.) |

| d. | Anti-dilution Protection |

If the Company issues or sells, or
is deemed by the express provisions of AOA’s subsection to have issued or sold, additional shares for an effective price which
is less than the applicable conversion price then in effect for any series of preferred share, then and in each such case, the conversion
price then in effect for such preferred shares shall be reduced, concurrently with such issue or sale, for no additional consideration,
as described in the AOA.

| e. | Liquidation Preference |

In an Exit Event (IPO, or